Delivery Order SPE2DX22D0010-SPE2D826FBB26
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Amphetamine Mix Tablets 20mg, with a ceiling value of $2,454.12 and an ultimate completion date of August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procedures. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Amphetamine Mix Tablets 20mg, valued at $1,989.00. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Amphetamine Mix Tablets 15mg. This competitively awarded, non-set-aside delivery order carries a ceiling value of $4,108.42 and a firm fixed price structure, with an ultimate completion date of September 2, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix Tablets 20mg with a ceiling value of $2,386.80. This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The contract involves no set-aside designation and will be performed at the contractor's facility in...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Amphetamine Mix Tablets 20mg, valued at $1,247.04. This is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Amphetamine Mix Tablets 20mg. This competitively awarded, non-set-aside contract carries a ceiling value of $1,247.04 with a firm fixed price structure and an ultimate completion date of October 27, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. As a major...
- The Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a $4,238.84 delivery order on July 28, 2025, for the supply of Amphetamine Mix Tablets 15mg. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action issued under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Amphetamine Mix Tablets 20mg with a ceiling value of $5,263.68. This firm fixed-price delivery order is scheduled for completion by November 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for Amphetamine Mix Tablets 5mg, with a ceiling value of $1,886.73 and a firm fixed price structure. The order is due for completion by August 4, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Amphetamine Mix Tablets 5mg, with a contract ceiling value of $1,080.39 and an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a single-line pharmaceutical supply action under the company's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBB26Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for amphetamine mix tablets (20mg) on November 13, 2025, with a contract ceiling value of $4,987.68 and an ultimate completion date of November 14, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location and will deliver the pharmaceutical product to support federal medical procurement needs. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp functions as a major pharmaceutical distributor for the Department of Defense, supplying a comprehensive range of medications and medical supplies across multiple therapeutic domains to support military healthcare systems, the Defense Health Agency, and other federal government entities. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/13/25 |